Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases
- 17 October 2012
- journal article
- Published by Springer Science and Business Media LLC in CardioVascular and Interventional Radiology
- Vol. 36 (3), 724-730
- https://doi.org/10.1007/s00270-012-0500-3
Abstract
To analyze the factors associated with favorable survival in patients with inoperable colorectal lung metastases treated with percutaneous image-guided radiofrequency ablation. Between 2002 and 2011, a total of 398 metastases were ablated in 122 patients (87 male, median age 68 years, range 29–90 years) at 256 procedures. Percutaneous CT-guided cool-tip radiofrequency ablation was performed under sedation/general anesthesia. Maximum tumor size, number of tumors ablated, number of procedures, concurrent/prior liver ablation, previous liver or lung resection, systemic chemotherapy, disease-free interval from primary resection to lung metastasis, and survival from first ablation were recorded prospectively. Kaplan–Meier analysis was performed, and factors were compared by log rank test. The initial number of metastases ablated was 2.3 (range 1–8); the total number was 3.3 (range 1–15). The maximum tumor diameter was 1.7 (range 0.5–4) cm, and the number of procedures was 2 (range 1–10). The major complication rate was 3.9 %. Overall median and 3-year survival rate were 41 months and 57 %. Survival was better in patients with smaller tumors—a median of 51 months, with 3-year survival of 64 % for tumors 2 cm or smaller versus 31 months and 44 % for tumors 2.1–4 cm (p = 0.08). The number of metastases ablated and whether the tumors were unilateral or bilateral did not affect survival. The presence of treated liver metastases, systemic chemotherapy, or prior lung resection did not affect survival. Three-year survival of 57 % in patients with inoperable colorectal lung metastases is better than would be expected with chemotherapy alone. Patients with inoperable but small-volume colorectal lung metastases should be referred for ablation.Keywords
This publication has 26 references indexed in Scilit:
- Indications and approach to surgical resection of lung metastasesJournal of Surgical Oncology, 2010
- Early Indicators of Treatment Success After Percutaneous Radiofrequency of Pulmonary TumorsCardioVascular and Interventional Radiology, 2009
- Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)The Lancet Oncology, 2008
- Radiofrequency ablation of lung metastases: factors influencing successEuropean Radiology, 2007
- Surgical Resection of Pulmonary Metastases From Colorectal Cancer: A Systematic Review of Published SeriesThe Annals of Thoracic Surgery, 2007
- Pulmonary Radiofrequency Ablation: Long-term Safety and Efficacy in 153 PatientsRadiology, 2007
- Radiofrequency Ablation for the Treatment of Unresectable Lung Metastases in Patients with Colorectal Cancer: A Multicenter Study in JapanJournal of Vascular and Interventional Radiology, 2007
- Percutaneous Radiofrequency Ablation of Pulmonary Metastases from Colorectal Carcinoma: Prognostic Determinants for SurvivalAnnals of Surgical Oncology, 2006
- Image-guided Tumor Ablation: Standardization of Terminology and Reporting CriteriaRadiology, 2005
- Radiofrequency Ablation of 40 Lung Neoplasms: Preliminary ResultsAmerican Journal of Roentgenology, 2004